Allied Corp Files for Full Psilocybin Patent for Psilonex™ Rx Pharmaceutical

[admin]

KELOWNA, British Columbia, March 16, 2022 (GLOBE NEWSWIRE) -- Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID) is pleased to announce that it has successfully filed for a full patent regarding “DOSING REGIMES OF PHARMACEUTICAL AND NUTRACEUTICAL MUSHROOM AND CANNABIS COMPOSITIONS AND THEIR USE TO TREAT CNS DISORDERS AND IMPROVE MENTAL HEALTH”. Due to the time stamp of the previous filing of Allied’s provisional patent No. 63/160,235, filed March 12, 2021, Allied now claims priority with reg